International Corporate Transactions TRANSACTIONAL

Our extensive experience in all aspects of cross-border transactions includes corporate finance, venture capital, mergers and acquisitions, and joint ventures. Bringing together transactional, securities, tax, antitrust and intellectual property lawyers from North America, Europe and Asia, we offer flexible, multidisciplinary resources to clients with global operations and interests. International matters have included:

  • Numerous venture capital transactions, as investor and company counsel, in the UK and Germany, including representation of BioVex (£17 million), Southampton Photonics ($15 million) and U3 Pharma (€12 million)
  • Representation of Bookham Technology in its $330 million acquisition of New Focus, a US-based public company
  • Numerous M&A transactions for Lufthansa, including its acquisition of a 30% stake in bmi British Midland, and joint ventures for its cargo and aircraft maintenance businesses
  • The $700 million merger of Parthus Technologies, an Irish public company, with a division of DSP Group, managed in Israel
  • Formation of the Star Alliance—the largest airline alliance in the world, comprising more than 15 international carriers

With the EU’s chemicals regulation, REACH, we have assembled an interdisciplinary team of lawyers who not only have significant experience with all key aspects of REACH, but can also advise companies on how best to position themselves in light of globally intensifying environmental issues in Europe, the Americas (US) and Asia (China). 

Bain, Mick

Mick Bain

Partner

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Boot, Jeannette K.

Jeannette K. Boot

Partner

+1 212 295 6507 (t)

jeannette.boot@wilmerhale.com

Borden, Mark G.

Mark G. Borden

Partner

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Bothwick, Jay E.

Jay E. Bothwick

Partner

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Braun, Martin

Dr. Martin Braun

Partner

+49 69 27 10 78 207 (t)

martin.braun@wilmerhale.com

Brown, Lillian

Lillian Brown

Partner

+1 202 663 6743 (t)

lillian.brown@wilmerhale.com

Buckland, Peter

Peter Buckland

Partner

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Coates, Sam

Samuel S. Coates

Partner

+1 650 858 6000 (t)

samuel.coates@wilmerhale.com

Publications & News

View

May 3, 2016

Selected 2016 Life Sciences Transactions

Recognized both globally and nationally for its leading life sciences practice, WilmerHale has more than four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

May 3, 2016

Selected 2016 Strategic Alliances, Joint Venture and Licensing Transactions

Our corporate, licensing, intellectual property and regulatory lawyers regularly handle a broad range of strategic alliance, joint venture, licensing,
collaboration, product development, outsourcing, manufacturing, distribution and similar agreements, including many significant deals that are helping to shape the future of science, technology and commerce.

May 3, 2016

Selected 2016 Technology Transactions

For more than four decades, we have represented technology clients in venture capital financings, public offerings, and mergers and acquisitions; handled their licensing, outsourcing, services, joint venture, development and distribution transactions throughout the world; protected their innovations through patent prosecution and portfolio development; defended their interests in enterprise-critical patent litigation; and navigated regulatory issues vital to their success.

May 2, 2016

WilmerHale Expands West Coast Corporate Practice With Two Partner Hires

WilmerHale is pleased to welcome Partners Christopher Rose and Eric Hwang to the firm's Los Angeles and Palo Alto offices, respectively.

March 24, 2016

2016 Corporate Reports

WilmerHale's annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

February 11, 2016

Selected 2016 M&A Transactions

In 2015, we advised clients throughout the United States and Europe on more than 75 M&A transactions providing guidance in areas including corporate, securities, antitrust and tax. Since 2004, we have participated in more than 1,200 mergers and acquisitions with a total value in excess of $500 billion, ranging from sales of VC-backed companies to multibillion-dollar global mergers.

February 11, 2016

Selected 2016 Public Offerings and Rule 144A Placements

In 2015, we handled nearly 50 public offerings and Rule 144A placements raising approximately $20 billion, for leading companies in life sciences, technology, financial services, communications and other industries.

February 2, 2016

Global Anti-Bribery Year-in-Review: 2015 Developments and Predictions for 2016

Among other significant developments, 2015 saw the U.S. Department of Justice (the “DOJ” or the “Department”) document a policy priority of holding individuals accountable for corporate wrongdoing. This policy was laid out in the “Yates Memorandum”—announced by Deputy Assistant Attorney General Sally Quillian Yates—and related changes the DOJ made to the U.S. Attorney’s Manual.

January 14, 2016

China Issues Updated Telecommunications Services Catalogue

China has for the first time in 12 years issued a new edition of the Telecommunications Services Catalogue to replace the badly outdated 2003 version issued shortly after China's WTO accession.

January 12, 2016

WilmerHale Named Among Top Three Life Sciences Law Firms

WilmerHale has been named among the top three Best Life Sciences Law Firms for 2016 in the inaugural Life Science Index.